0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Antivenom Sales Market Report 2023
Published Date: January 2023
|
Report Code: QYRE-Auto-19N8983
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Antivenom Market Outlook 2022
BUY CHAPTERS

Global Antivenom Sales Market Report 2023

Code: QYRE-Auto-19N8983
Report
January 2023
Pages:125
QYResearch
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
Antivenom, also known as antivenin, venom antiserum and antivenom immunoglobulin, is a medication made from antibodies which is used to treat certain venomous bites and stings. They are only recommended if there is significant toxicity or a high risk of toxicity. The specific antivenom needed depends on the species involved. It is given by injection.
Market Analysis and Insights: Global Antivenom Market

Due to the COVID-19 pandemic, the global Antivenom market size is estimated to be worth US$ 959.2 million in 2022 and is forecast to a readjusted size of US$ 1283.7 million by 2029 with a CAGR of 4.2% during the forecast period 2023-2029.

Fully considering the economic change by this health crisis, Polyvalent antivenom accounting for % of the Antivenom global market in 2022, is projected to value US$ million by 2029, growing at a revised % CAGR from 2023 to 2029.

While Non-profit Institutions segment is altered to an % CAGR throughout this forecast period.
CSL is the world leading manufacturer in global Anti-Venom market with the market share of 27%, in terms of revenue, followed by Merck, BTG, Pfizer, Haffkine Bio-Pharmaceutical, Rare Disease Therapeutics, Flynn Pharma, Vins Bioproducts, Bharat Serums and Vaccines, Serum Biotech and MicroPharm. These 11 companies accounted for 68% of the revenue market share in 2019. Asia-Pacific, Middle East and Africa are the largest consumption regions, occupied about 77% of market share, in terms of volume. The application of Anti-Venom in hospital and clinics take the main global shares. The polyvalent Anti-Venom takes more global revenue shares compared to the Monovalent Anti-Venom, which accounts for 67% in 2019.
Global Antivenom Scope and Market Size
The global Antivenom market is segmented by company, region (country), type and application. Players, stakeholders, and other participants in the global Antivenom market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), type and application for the period 2018-2029.

Segment by Type

Polyvalent antivenom
Monovalent antivenom

Segment by Application

Non-profit Institutions
Hospitals and Clinic

BY REGION

United States
Europe
China
Japan
Southeast Asia
India
Other Regions

BY COMPANY

CSL
Merck
BTG
Pfizer
Haffkine Bio-Pharmaceutical
Rare Disease Therapeutics
Flynn Pharma
Vins Bioproducts
Bharat Serums and Vaccines
Serum Biotech
MicroPharm
1 Antivenom Market Overview
1.1 Antivenom Product Scope
1.2 Antivenom Segment by Type
1.2.1 Global Antivenom Sales by Type (2018 & 2022 & 2029)
1.2.2 Polyvalent antivenom
1.2.3 Monovalent antivenom
1.3 Antivenom Segment by Application
1.3.1 Global Antivenom Sales Comparison by Application (2018 & 2022 & 2029)
1.3.2 Non-profit Institutions
1.3.3 Hospitals and Clinic
1.4 Antivenom Market Estimates and Forecasts (2018-2029)
1.4.1 Global Antivenom Market Size in Value Growth Rate (2018-2029)
1.4.2 Global Antivenom Market Size in Volume Growth Rate (2018-2029)
1.4.3 Global Antivenom Price Trends (2018-2029)
2 Antivenom Estimates and Forecasts by Region
2.1 Global Antivenom Market Size by Region: 2018 VS 2022 VS 2029
2.2 Global Antivenom Retrospective Market Scenario by Region (2018-2023)
2.2.1 Global Antivenom Sales Market Share by Region (2018-2023)
2.2.2 Global Antivenom Revenue Market Share by Region (2018-2023)
2.3 Global Antivenom Market Estimates and Forecasts by Region (2024-2029)
2.3.1 Global Antivenom Sales Estimates and Forecasts by Region (2024-2029)
2.3.2 Global Antivenom Revenue Forecast by Region (2024-2029)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Antivenom Estimates and Projections (2018-2029)
2.4.2 Europe Antivenom Estimates and Projections (2018-2029)
2.4.3 China Antivenom Estimates and Projections (2018-2029)
2.4.4 Japan Antivenom Estimates and Projections (2018-2029)
2.4.5 Southeast Asia Antivenom Estimates and Projections (2018-2029)
2.4.6 India Antivenom Estimates and Projections (2018-2029)
3 Global Antivenom Competition Landscape by Players
3.1 Global Top Antivenom Players by Sales (2018-2023)
3.2 Global Top Antivenom Players by Revenue (2018-2023)
3.3 Global Antivenom Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Antivenom as of 2022)
3.4 Global Antivenom Average Price by Company (2018-2023)
3.5 Manufacturers Antivenom Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Antivenom Market Size by Type
4.1 Global Antivenom Historic Market Review by Type (2018-2023)
4.1.1 Global Antivenom Sales by Type (2018-2023)
4.1.2 Global Antivenom Revenue by Type (2018-2023)
4.1.3 Global Antivenom Price by Type (2018-2023)
4.2 Global Antivenom Market Estimates and Forecasts by Type (2024-2029)
4.2.1 Global Antivenom Sales Forecast by Type (2024-2029)
4.2.2 Global Antivenom Revenue Forecast by Type (2024-2029)
4.2.3 Global Antivenom Price Forecast by Type (2024-2029)
5 Global Antivenom Market Size by Application
5.1 Global Antivenom Historic Market Review by Application (2018-2023)
5.1.1 Global Antivenom Sales by Application (2018-2023)
5.1.2 Global Antivenom Revenue by Application (2018-2023)
5.1.3 Global Antivenom Price by Application (2018-2023)
5.2 Global Antivenom Market Estimates and Forecasts by Application (2024-2029)
5.2.1 Global Antivenom Sales Forecast by Application (2024-2029)
5.2.2 Global Antivenom Revenue Forecast by Application (2024-2029)
5.2.3 Global Antivenom Price Forecast by Application (2024-2029)
6 United States Antivenom Market Facts & Figures
6.1 United States Antivenom Sales by Company
6.1.1 United States Antivenom Sales by Company (2018-2023)
6.1.2 United States Antivenom Revenue by Company (2018-2023)
6.2 United States Antivenom Sales Breakdown by Type
6.2.1 United States Antivenom Sales Breakdown by Type (2018-2023)
6.2.2 United States Antivenom Sales Breakdown by Type (2024-2029)
6.3 United States Antivenom Sales Breakdown by Application
6.3.1 United States Antivenom Sales Breakdown by Application (2018-2023)
6.3.2 United States Antivenom Sales Breakdown by Application (2024-2029)
7 Europe Antivenom Market Facts & Figures
7.1 Europe Antivenom Sales by Company
7.1.1 Europe Antivenom Sales by Company (2018-2023)
7.1.2 Europe Antivenom Revenue by Company (2018-2023)
7.2 Europe Antivenom Sales Breakdown by Type
7.2.1 Europe Antivenom Sales Breakdown by Type (2018-2023)
7.2.2 Europe Antivenom Sales Breakdown by Type (2024-2029)
7.3 Europe Antivenom Sales Breakdown by Application
7.3.1 Europe Antivenom Sales Breakdown by Application (2018-2023)
7.3.2 Europe Antivenom Sales Breakdown by Application (2024-2029)
8 China Antivenom Market Facts & Figures
8.1 China Antivenom Sales by Company
8.1.1 China Antivenom Sales by Company (2018-2023)
8.1.2 China Antivenom Revenue by Company (2018-2023)
8.2 China Antivenom Sales Breakdown by Type
8.2.1 China Antivenom Sales Breakdown by Type (2018-2023)
8.2.2 China Antivenom Sales Breakdown by Type (2024-2029)
8.3 China Antivenom Sales Breakdown by Application
8.3.1 China Antivenom Sales Breakdown by Application (2018-2023)
8.3.2 China Antivenom Sales Breakdown by Application (2024-2029)
9 Japan Antivenom Market Facts & Figures
9.1 Japan Antivenom Sales by Company
9.1.1 Japan Antivenom Sales by Company (2018-2023)
9.1.2 Japan Antivenom Revenue by Company (2018-2023)
9.2 Japan Antivenom Sales Breakdown by Type
9.2.1 Japan Antivenom Sales Breakdown by Type (2018-2023)
9.2.2 Japan Antivenom Sales Breakdown by Type (2024-2029)
9.3 Japan Antivenom Sales Breakdown by Application
9.3.1 Japan Antivenom Sales Breakdown by Application (2018-2023)
9.3.2 Japan Antivenom Sales Breakdown by Application (2024-2029)
10 Southeast Asia Antivenom Market Facts & Figures
10.1 Southeast Asia Antivenom Sales by Company
10.1.1 Southeast Asia Antivenom Sales by Company (2018-2023)
10.1.2 Southeast Asia Antivenom Revenue by Company (2018-2023)
10.2 Southeast Asia Antivenom Sales Breakdown by Type
10.2.1 Southeast Asia Antivenom Sales Breakdown by Type (2018-2023)
10.2.2 Southeast Asia Antivenom Sales Breakdown by Type (2024-2029)
10.3 Southeast Asia Antivenom Sales Breakdown by Application
10.3.1 Southeast Asia Antivenom Sales Breakdown by Application (2018-2023)
10.3.2 Southeast Asia Antivenom Sales Breakdown by Application (2024-2029)
11 India Antivenom Market Facts & Figures
11.1 India Antivenom Sales by Company
11.1.1 India Antivenom Sales by Company (2018-2023)
11.1.2 India Antivenom Revenue by Company (2018-2023)
11.2 India Antivenom Sales Breakdown by Type
11.2.1 India Antivenom Sales Breakdown by Type (2018-2023)
11.2.2 India Antivenom Sales Breakdown by Type (2024-2029)
11.3 India Antivenom Sales Breakdown by Application
11.3.1 India Antivenom Sales Breakdown by Application (2018-2023)
11.3.2 India Antivenom Sales Breakdown by Application (2024-2029)
12 Company Profiles and Key Figures in Antivenom Business
12.1 CSL
12.1.1 CSL Corporation Information
12.1.2 CSL Business Overview
12.1.3 CSL Antivenom Sales, Revenue and Gross Margin (2018-2023)
12.1.4 CSL Antivenom Products Offered
12.1.5 CSL Recent Development
12.2 Merck
12.2.1 Merck Corporation Information
12.2.2 Merck Business Overview
12.2.3 Merck Antivenom Sales, Revenue and Gross Margin (2018-2023)
12.2.4 Merck Antivenom Products Offered
12.2.5 Merck Recent Development
12.3 BTG
12.3.1 BTG Corporation Information
12.3.2 BTG Business Overview
12.3.3 BTG Antivenom Sales, Revenue and Gross Margin (2018-2023)
12.3.4 BTG Antivenom Products Offered
12.3.5 BTG Recent Development
12.4 Pfizer
12.4.1 Pfizer Corporation Information
12.4.2 Pfizer Business Overview
12.4.3 Pfizer Antivenom Sales, Revenue and Gross Margin (2018-2023)
12.4.4 Pfizer Antivenom Products Offered
12.4.5 Pfizer Recent Development
12.5 Haffkine Bio-Pharmaceutical
12.5.1 Haffkine Bio-Pharmaceutical Corporation Information
12.5.2 Haffkine Bio-Pharmaceutical Business Overview
12.5.3 Haffkine Bio-Pharmaceutical Antivenom Sales, Revenue and Gross Margin (2018-2023)
12.5.4 Haffkine Bio-Pharmaceutical Antivenom Products Offered
12.5.5 Haffkine Bio-Pharmaceutical Recent Development
12.6 Rare Disease Therapeutics
12.6.1 Rare Disease Therapeutics Corporation Information
12.6.2 Rare Disease Therapeutics Business Overview
12.6.3 Rare Disease Therapeutics Antivenom Sales, Revenue and Gross Margin (2018-2023)
12.6.4 Rare Disease Therapeutics Antivenom Products Offered
12.6.5 Rare Disease Therapeutics Recent Development
12.7 Flynn Pharma
12.7.1 Flynn Pharma Corporation Information
12.7.2 Flynn Pharma Business Overview
12.7.3 Flynn Pharma Antivenom Sales, Revenue and Gross Margin (2018-2023)
12.7.4 Flynn Pharma Antivenom Products Offered
12.7.5 Flynn Pharma Recent Development
12.8 Vins Bioproducts
12.8.1 Vins Bioproducts Corporation Information
12.8.2 Vins Bioproducts Business Overview
12.8.3 Vins Bioproducts Antivenom Sales, Revenue and Gross Margin (2018-2023)
12.8.4 Vins Bioproducts Antivenom Products Offered
12.8.5 Vins Bioproducts Recent Development
12.9 Bharat Serums and Vaccines
12.9.1 Bharat Serums and Vaccines Corporation Information
12.9.2 Bharat Serums and Vaccines Business Overview
12.9.3 Bharat Serums and Vaccines Antivenom Sales, Revenue and Gross Margin (2018-2023)
12.9.4 Bharat Serums and Vaccines Antivenom Products Offered
12.9.5 Bharat Serums and Vaccines Recent Development
12.10 Serum Biotech
12.10.1 Serum Biotech Corporation Information
12.10.2 Serum Biotech Business Overview
12.10.3 Serum Biotech Antivenom Sales, Revenue and Gross Margin (2018-2023)
12.10.4 Serum Biotech Antivenom Products Offered
12.10.5 Serum Biotech Recent Development
12.11 MicroPharm
12.11.1 MicroPharm Corporation Information
12.11.2 MicroPharm Business Overview
12.11.3 MicroPharm Antivenom Sales, Revenue and Gross Margin (2018-2023)
12.11.4 MicroPharm Antivenom Products Offered
12.11.5 MicroPharm Recent Development
13 Antivenom Manufacturing Cost Analysis
13.1 Antivenom Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Antivenom
13.4 Antivenom Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Antivenom Distributors List
14.3 Antivenom Customers
15 Market Dynamics
15.1 Antivenom Industry Trends
15.2 Antivenom Market Drivers
15.3 Antivenom Market Challenges
15.4 Antivenom Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
List of Tables
    Table 1. Global Antivenom Sales (US$ Million) Growth Rate by Type (2018 & 2022 & 2029)
    Table 2. Global Antivenom Sales ((US$ Million)) Comparison by Application (2018 & 2022 & 2029)
    Table 3. Global Antivenom Market Size (US$ Million) by Region: 2018 VS 2022 VS 2029
    Table 4. Global Antivenom Sales (K Vials) by Region (2018-2023)
    Table 5. Global Antivenom Sales Market Share by Region (2018-2023)
    Table 6. Global Antivenom Revenue (US$ Million) Market Share by Region (2018-2023))
    Table 7. Global Antivenom Revenue Share by Region (2018-2023)
    Table 8. Global Antivenom Sales (K Vials) Forecast by Region (2024-2029)
    Table 9. Global Antivenom Sales Market Share Forecast by Region (2024-2029)
    Table 10. Global Antivenom Revenue (US$ Million) Forecast by Region (2024-2029)
    Table 11. Global Antivenom Revenue Share Forecast by Region (2024-2029)
    Table 12. Global Antivenom Sales by Company (K Vials) & (2018-2023)
    Table 13. Global Antivenom Sales Share by Company (2018-2023)
    Table 14. Global Antivenom Revenue by Company (US$ Million) & (2018-2023)
    Table 15. Global Antivenom Revenue Share by Company (2018-2023)
    Table 16. Global Antivenom by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antivenom as of 2022)
    Table 17. Global Market Antivenom Average Price by Company (USD/Vial) & (2018-2023)
    Table 18. Manufacturers Antivenom Manufacturing Sites and Area Served
    Table 19. Manufacturers Antivenom Product Type
    Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 21. Global Antivenom Sales by Type (2018-2023) & (K Vials)
    Table 22. Global Antivenom Sales Share by Type (2018-2023)
    Table 23. Global Antivenom Revenue by Type (2018-2023) & (US$ Million)
    Table 24. Global Antivenom Price by Type (2018-2023) & (USD/Vial)
    Table 25. Global Antivenom Sales by Type (2024-2029)
    Table 26. Global Antivenom Revenue by Type (2024-2029) & (US$ Million)
    Table 27. Global Antivenom Revenue Share by Type (2024-2029)
    Table 28. Global Antivenom Price by Type (2024-2029) & (USD/Vial)
    Table 29. Global Antivenom Sales by Application (2018-2023) & (K Vials)
    Table 30. Global Antivenom Sales Share by Application (2018-2023)
    Table 31. Global Antivenom Revenue by Application (2018-2023) & (US$ Million)
    Table 32. Global Antivenom Price by Application (2018-2023) & (USD/Vial)
    Table 33. Global Antivenom Sales by Application (2024-2029) & (K Vials)
    Table 34. Global Antivenom Sales Share by Application (2024-2029)
    Table 35. Global Antivenom Revenue by Application (2024-2029) & (US$ Million)
    Table 36. Global Antivenom Revenue Share by Application (2024-2029)
    Table 37. Global Antivenom Price by Application (2024-2029) & (USD/Vial)
    Table 38. United States Antivenom Sales by Company (2018-2023) & (K Vials)
    Table 39. United States Antivenom Sales Market Share by Company (2018-2023)
    Table 40. United States Antivenom Revenue by Company (2018-2023) & (US$ Million)
    Table 41. United States Antivenom Revenue Market Share by Company (2018-2023)
    Table 42. United States Antivenom Sales by Type (2018-2023) & (K Vials)
    Table 43. United States Antivenom Sales Market Share by Type (2018-2023)
    Table 44. United States Antivenom Sales by Type (2024-2029) & (K Vials)
    Table 45. United States Antivenom Sales Market Share by Type (2024-2029)
    Table 46. United States Antivenom Sales by Application (2018-2023) & (K Vials)
    Table 47. United States Antivenom Sales Market Share by Application (2018-2023)
    Table 48. United States Antivenom Sales by Application (2024-2029) & (K Vials)
    Table 49. United States Antivenom Sales Market Share by Application (2024-2029)
    Table 50. Europe Antivenom Sales by Company (2018-2023) & (K Vials)
    Table 51. Europe Antivenom Sales Market Share by Company (2018-2023)
    Table 52. Europe Antivenom Revenue by Company (2018-2023) & (US$ Million)
    Table 53. Europe Antivenom Revenue Market Share by Company (2018-2023)
    Table 54. Europe Antivenom Sales by Type (2018-2023) & (K Vials)
    Table 55. Europe Antivenom Sales Market Share by Type (2018-2023)
    Table 56. Europe Antivenom Sales by Type (2024-2029) & (K Vials)
    Table 57. Europe Antivenom Sales Market Share by Type (2024-2029)
    Table 58. Europe Antivenom Sales by Application (2018-2023) & (K Vials)
    Table 59. Europe Antivenom Sales Market Share by Application (2018-2023)
    Table 60. Europe Antivenom Sales by Application (2024-2029) & (K Vials)
    Table 61. Europe Antivenom Sales Market Share by Application (2024-2029)
    Table 62. China Antivenom Sales by Company (2018-2023) & (K Vials)
    Table 63. China Antivenom Sales Market Share by Company (2018-2023)
    Table 64. China Antivenom Revenue by Company (2018-2023) & (US$ Million)
    Table 65. China Antivenom Revenue Market Share by Company (2018-2023)
    Table 66. China Antivenom Sales by Type (2018-2023) & (K Vials)
    Table 67. China Antivenom Sales Market Share by Type (2018-2023)
    Table 68. China Antivenom Sales by Type (2024-2029) & (K Vials)
    Table 69. China Antivenom Sales Market Share by Type (2024-2029)
    Table 70. China Antivenom Sales by Application (2018-2023) & (K Vials)
    Table 71. China Antivenom Sales Market Share by Application (2018-2023)
    Table 72. China Antivenom Sales by Application (2024-2029) & (K Vials)
    Table 73. China Antivenom Sales Market Share by Application (2024-2029)
    Table 74. Japan Antivenom Sales by Company (2018-2023) & (K Vials)
    Table 75. Japan Antivenom Sales Market Share by Company (2018-2023)
    Table 76. Japan Antivenom Revenue by Company (2018-2023) & (US$ Million)
    Table 77. Japan Antivenom Revenue Market Share by Company (2018-2023)
    Table 78. Japan Antivenom Sales by Type (2018-2023) & (K Vials)
    Table 79. Japan Antivenom Sales Market Share by Type (2018-2023)
    Table 80. Japan Antivenom Sales by Type (2024-2029) & (K Vials)
    Table 81. Japan Antivenom Sales Market Share by Type (2024-2029)
    Table 82. Japan Antivenom Sales by Application (2018-2023) & (K Vials)
    Table 83. Japan Antivenom Sales Market Share by Application (2018-2023)
    Table 84. Japan Antivenom Sales by Application (2024-2029) & (K Vials)
    Table 85. Japan Antivenom Sales Market Share by Application (2024-2029)
    Table 86. Southeast Asia Antivenom Sales by Company (2018-2023) & (K Vials)
    Table 87. Southeast Asia Antivenom Sales Market Share by Company (2018-2023)
    Table 88. Southeast Asia Antivenom Revenue by Company (2018-2023) & (US$ Million)
    Table 89. Southeast Asia Antivenom Revenue Market Share by Company (2018-2023)
    Table 90. Southeast Asia Antivenom Sales by Type (2018-2023) & (K Vials)
    Table 91. Southeast Asia Antivenom Sales Market Share by Type (2018-2023)
    Table 92. Southeast Asia Antivenom Sales by Type (2024-2029) & (K Vials)
    Table 93. Southeast Asia Antivenom Sales Market Share by Type (2024-2029)
    Table 94. Southeast Asia Antivenom Sales by Application (2018-2023) & (K Vials)
    Table 95. Southeast Asia Antivenom Sales Market Share by Application (2018-2023)
    Table 96. Southeast Asia Antivenom Sales by Application (2024-2029) & (K Vials)
    Table 97. Southeast Asia Antivenom Sales Market Share by Application (2024-2029)
    Table 98. India Antivenom Sales by Company (2018-2023) & (K Vials)
    Table 99. India Antivenom Sales Market Share by Company (2018-2023)
    Table 100. India Antivenom Revenue by Company (2018-2023) & (US$ Million)
    Table 101. India Antivenom Revenue Market Share by Company (2018-2023)
    Table 102. India Antivenom Sales by Type (2018-2023) & (K Vials)
    Table 103. India Antivenom Sales Market Share by Type (2018-2023)
    Table 104. India Antivenom Sales by Type (2024-2029) & (K Vials)
    Table 105. India Antivenom Sales Market Share by Type (2024-2029)
    Table 106. India Antivenom Sales by Application (2018-2023) & (K Vials)
    Table 107. India Antivenom Sales Market Share by Application (2018-2023)
    Table 108. India Antivenom Sales by Application (2024-2029) & (K Vials)
    Table 109. India Antivenom Sales Market Share by Application (2024-2029)
    Table 110. CSL Corporation Information
    Table 111. CSL Description and Business Overview
    Table 112. CSL Antivenom Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2018-2023)
    Table 113. CSL Antivenom Product
    Table 114. CSL Recent Development
    Table 115. Merck Corporation Information
    Table 116. Merck Description and Business Overview
    Table 117. Merck Antivenom Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2018-2023)
    Table 118. Merck Antivenom Product
    Table 119. Merck Recent Development
    Table 120. BTG Corporation Information
    Table 121. BTG Description and Business Overview
    Table 122. BTG Antivenom Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2018-2023)
    Table 123. BTG Antivenom Product
    Table 124. BTG Recent Development
    Table 125. Pfizer Corporation Information
    Table 126. Pfizer Description and Business Overview
    Table 127. Pfizer Antivenom Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2018-2023)
    Table 128. Pfizer Antivenom Product
    Table 129. Pfizer Recent Development
    Table 130. Haffkine Bio-Pharmaceutical Corporation Information
    Table 131. Haffkine Bio-Pharmaceutical Description and Business Overview
    Table 132. Haffkine Bio-Pharmaceutical Antivenom Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2018-2023)
    Table 133. Haffkine Bio-Pharmaceutical Antivenom Product
    Table 134. Haffkine Bio-Pharmaceutical Recent Development
    Table 135. Rare Disease Therapeutics Corporation Information
    Table 136. Rare Disease Therapeutics Description and Business Overview
    Table 137. Rare Disease Therapeutics Antivenom Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2018-2023)
    Table 138. Rare Disease Therapeutics Antivenom Product
    Table 139. Rare Disease Therapeutics Recent Development
    Table 140. Flynn Pharma Corporation Information
    Table 141. Flynn Pharma Description and Business Overview
    Table 142. Flynn Pharma Antivenom Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2018-2023)
    Table 143. Flynn Pharma Antivenom Product
    Table 144. Flynn Pharma Recent Development
    Table 145. Vins Bioproducts Corporation Information
    Table 146. Vins Bioproducts Antivenom Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2018-2023)
    Table 147. Vins Bioproducts Description and Business Overview
    Table 148. Vins Bioproducts Antivenom Product
    Table 149. Vins Bioproducts Recent Development
    Table 150. Bharat Serums and Vaccines Corporation Information
    Table 151. Bharat Serums and Vaccines Antivenom Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2018-2023)
    Table 152. Bharat Serums and Vaccines Description and Business Overview
    Table 153. Bharat Serums and Vaccines Antivenom Product
    Table 154. Bharat Serums and Vaccines Recent Development
    Table 155. Serum Biotech Corporation Information
    Table 156. Serum Biotech Description and Business Overview
    Table 157. Serum Biotech Antivenom Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2018-2023)
    Table 158. Serum Biotech Antivenom Product
    Table 159. Serum Biotech Recent Development
    Table 160. MicroPharm Corporation Information
    Table 161. MicroPharm Description and Business Overview
    Table 162. MicroPharm Antivenom Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2018-2023)
    Table 163. MicroPharm Antivenom Product
    Table 164. MicroPharm Recent Development
    Table 165. Production Base and Market Concentration Rate of Raw Material
    Table 166. Key Suppliers of Raw Materials
    Table 167. Antivenom Distributors List
    Table 168. Antivenom Customers List
    Table 169. Antivenom Market Trends
    Table 170. Antivenom Market Drivers
    Table 171. Antivenom Market Challenges
    Table 172. Antivenom Market Restraints
    Table 173. Research Programs/Design for This Report
    Table 174. Key Data Information from Secondary Sources
    Table 175. Key Data Information from Primary Sources
List of Figures
    Figure 1. Antivenom Product Picture
    Figure 2. Global Antivenom Sales (US$ Million) by Type (2018 & 2022 & 2029)
    Figure 3. Global Antivenom Sales Market Share by Type in 2022 & 2029
    Figure 4. Polyvalent antivenom Product Picture
    Figure 5. Monovalent antivenom Product Picture
    Figure 6. Global Antivenom Sales (US$ Million) by Application (2018 & 2022 & 2029)
    Figure 7. Global Antivenom Sales Market Share by Application in 2022 & 2029
    Figure 8. Non-profit Institutions Examples
    Figure 9. Hospitals and Clinic Examples
    Figure 10. Global Antivenom Sales, (US$ Million), 2018 VS 2022 VS 2029
    Figure 11. Global Antivenom Sales Growth Rate (2018-2029) & (US$ Million)
    Figure 12. Global Antivenom Sales (K Vials) Growth Rate (2018-2029)
    Figure 13. Global Antivenom Price Trends Growth Rate (2018-2029) & (USD/Vial)
    Figure 14. Global Market Antivenom Market Size (US$ Million) by Region:2018 VS 2022 VS 2029
    Figure 15. Global Antivenom Revenue Market Share by Region: 2018 VS 2022
    Figure 16. United States Antivenom Revenue (US$ Million) Growth Rate (2018-2029)
    Figure 17. United States Antivenom Sales (K Vials) Growth Rate (2018-2029)
    Figure 18. Europe Antivenom Revenue (US$ Million) Growth Rate (2018-2029)
    Figure 19. Europe Antivenom Sales (US$ Million) Growth Rate (2018-2029)
    Figure 20. China Antivenom Revenue (US$ Million) Growth Rate (2018-2029)
    Figure 21. China Antivenom Sales (US$ Million) and Growth Rate (2018-2029)
    Figure 22. Japan Antivenom Revenue (US$ Million) Growth Rate (2018-2029)
    Figure 23. Japan Antivenom Sales (US$ Million) Growth Rate (2018-2029)
    Figure 24. Southeast Asia Antivenom Revenue (US$ Million) Growth Rate (2018-2029)
    Figure 25. Southeast Asia Antivenom Sales (US$ Million) Growth Rate (2018-2029)
    Figure 26. India Antivenom Revenue (US$ Million) Growth Rate (2018-2029)
    Figure 27. India Antivenom Sales (US$ Million) Growth Rate (2018-2029)
    Figure 28. Global 5 Largest Antivenom Players Market Share by Revenue in Antivenom: 2018 & 2022
    Figure 29. Antivenom Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
    Figure 30. Global Antivenom Revenue Share by Type (2018-2023)
    Figure 31. Global Antivenom Sales Share by Type (2024-2029)
    Figure 32. Global Antivenom Revenue Share by Type (2024-2029)
    Figure 33. Global Antivenom Revenue Share by Application (2018-2023)
    Figure 34. Global Antivenom Revenue Growth Rate by Application in 2018 & 2022
    Figure 35. Global Antivenom Sales Share by Application (2024-2029)
    Figure 36. Global Antivenom Revenue Share by Application (2024-2029)
    Figure 37. Key Raw Materials Price Trend
    Figure 38. Manufacturing Cost Structure of Antivenom
    Figure 39. Manufacturing Process Analysis of Antivenom
    Figure 40. Antivenom Industrial Chain Analysis
    Figure 41. Channels of Distribution
    Figure 42. Distributors Profiles
    Figure 43. Bottom-up and Top-down Approaches for This Report
    Figure 44. Data Triangulation
    Figure 45. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4000

This license allows only one user to access the PDF.
Electronic (PDF)

$6000

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$8000

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Sugar Content Detector Market Research Report 2023

120 Pages
Type: Report
Code: QYRE-Auto-14S11458
Tue Jan 31 00:00:00 UTC 2023

Add to Cart

Global Enteric Capsule Coating Market Research Report 2023

120 Pages
Type: Report
Code: QYRE-Auto-23P11132
Tue Jan 31 00:00:00 UTC 2023

Add to Cart

Global Automated Biomedical Testing Equipment Market Research Report 2023

120 Pages
Type: Report
Code: QYRE-Auto-20F9295
Mon Jan 30 00:00:00 UTC 2023

Add to Cart

Global Antibody Labeling Kits Market Research Report 2023

120 Pages
Type: Report
Code: QYRE-Auto-25E12937
Mon Jan 30 00:00:00 UTC 2023

Add to Cart